GLP-1 combination therapy Researched alongside GLP-1 agonists like semaglutide (CagriSema) in investigational obesity trials, still under study
Statements Author contributions ZJ: Writing original draft
J Diabetes Res 2018:1232583 Ikonomidis I, Pavlidis G, Thymis J, Birba D, Kalogeris A, Kousathana F, Kountouri A, Balampanis K, Parissis J, Andreadou I, Katogiannis K, Dimitriadis G, Bamias A, Iliodromitis E, Lambadiari V (2020) Effects of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and their combination on endothelial glycocalyx, arterial function, and myocardial work index in patients with type 2 diabetes mellitus after 12-month treatment
PMID 804137
Cox regression analyses were performed in a univariable and exploratory multivariable manner adjusting for selected clinical variables